BioLife Solutions, Inc. Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities
BioLife Solutions, Inc. (BLFS) had Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities of $0 as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities · last filed 2025-03-03
- 2024-12-31: Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities $0.00.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities $74.00K.
| Period end | Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 |
| 2023-12-31 | $74.00K 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |